Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy.
Pasquali S, Vallacchi V, Lalli L, Collini P, Barisella M, Romagosa C, Bague S, Coindre JM, Dei Tos AP, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Blay JY, Beveridge RD, Casiraghi E, Brich S, Renne SL, Bergamaschi L, Vergani B, Sbaraglia M, Casali PG, Rivoltini L, Stacchiotti S, Gronchi A.
Pasquali S, et al.
EBioMedicine. 2024 Aug;106:105220. doi: 10.1016/j.ebiom.2024.105220. Epub 2024 Jul 16.
EBioMedicine. 2024.
PMID: 39018755
Free PMC article.
Clinical Trial.